ReCerise Therapeutics Inc.is a bio-venture company that researches and develops targeted therapies
and comorbid diagnosis methods with the aim of specialized treatment for progressive liver diseases.
ReCerise is focused on R&D-oriented business development and is comprised ofleading experts in the fields of basic,
translational, and medicinal research and innovation.
At ReCerise, we are focused on securing our own original technologies,
based on specialized treatment and diagnosis strategies for diverse liver diseases.